Saghaie Lotfollah, Liu Dy, Hider Robert C
Department of Pharmaceutical Chemistry, School of Pharmacy and Pharmaceutical Sciences and Isfahan Pharmaceutical Sciences Research Center, Isfahan University of Medical Sciences, Isfahan, I.R. Iran.
Department of Pharmacy, King's College London, London, UK.
Res Pharm Sci. 2015 Jul-Aug;10(4):364-77.
Iron overload is a clinical problem which can be prevented by using iron chelating agents. An alternative method of relieving iron overload is to reduce iron absorption from the intestine by administering specific iron chelating agents, which can bind iron to form nonabsorbable complexes. Based on this strategy, a series of polymeric ligands containing the chelating moiety 3-hydroxypyridin-4-ones (HPOs) were synthesized. The synthetic route involves the benzylation of hydroxyl group of (2-methyl-3-hydroxypyran-4-one (maltol) and conversion of benzylated maltol to 3-benzyloxypyridin-4-one derivatives by using three suitable primary amines (2,6-diaminohexanoic acid (lysine) and 1,6-diaminohexane and 5-aminopentanol). The resulted compounds incorporated into polymer by copolymerization with acryloyl chloride using 2, 2'-azobisisobutyronitrile (AIBN) as the initiator. Finally, the benzyl groups of polymers were removed by catalytic hydrogenation (Pd/C). In this work, three final polymers of HPO derivatives namely poly-2-propylamido-6-(3- hydroxy -1,4-dihydro-2-methy-4-oxopyrid-1-yl) hexanoic acid, 6-(3-hydroxy-1, 4-dihydro-2-methyl-4-oxopyrid-1-yl) hexyl-1-polypropylamide and 5-(3-hydroxy-1-,4-dihydro-2-methyl-4-oxopyrid-1-yl)-1-polyacrylate pentane were synthesized. Identification and structural elucidation of compounds were achieved by proton nuclear magnetic resonance ((1)H NMR), carbon nuclear magnetic resonance ((13)C NMR) and infrared (IR) spectroscopy.
铁过载是一个可通过使用铁螯合剂预防的临床问题。缓解铁过载的另一种方法是通过给予特定的铁螯合剂来减少肠道对铁的吸收,这些螯合剂可与铁结合形成不可吸收的复合物。基于此策略,合成了一系列含有螯合部分3-羟基吡啶-4-酮(HPOs)的聚合物配体。合成路线包括(2-甲基-3-羟基吡喃-4-酮(麦芽酚))羟基的苄基化,以及使用三种合适的伯胺(2,6-二氨基己酸(赖氨酸)、1,6-二氨基己烷和5-氨基戊醇)将苄基化的麦芽酚转化为3-苄氧基吡啶-4-酮衍生物。所得化合物通过以2,2'-偶氮二异丁腈(AIBN)为引发剂与丙烯酰氯共聚而并入聚合物中。最后,通过催化氢化(Pd/C)除去聚合物的苄基。在这项工作中,合成了三种HPO衍生物的最终聚合物,即聚-2-丙基酰胺基-6-(3-羟基-1,4-二氢-2-甲基-4-氧代吡啶-1-基)己酸、6-(3-羟基-1,4-二氢-2-甲基-4-氧代吡啶-1-基)己基-1-聚丙基酰胺和5-(3-羟基-1,4-二氢-2-甲基-4-氧代吡啶-1-基)-1-聚丙烯酸戊烷。通过质子核磁共振((1)H NMR)、碳核磁共振((13)C NMR)和红外(IR)光谱对化合物进行了鉴定和结构解析。